EN   EN 
 
 
 EUROPEAN  
COMMISSION   
Brussels, XXX   
[…](2024) XXX  draft  
ANNEX  
 
ANNEX  
to the  
Commission Delegated Regulation  
amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council 
as regards the harmonised classification and labelling of certain substances      
   
EN 1  EN ANNEX  
Part 3, Table 3 , of Annex  VI is amended as follows:  
 
(1) the following entries are inserted  following the consecutive order of the index numbers corresponding to each entry : 
 
Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
‘005-022-00-4 perboric acid, sodium salt 
[1] 
perboric acid, sodium salt, 
monohydrate [2]  
perboric acid (HBO(O 2)), 
sodium salt, monohydrate  
[3] sodium peroxoborate 
[4] 
sodium perborate [ 5] 234-390-0 [1]  
234-390-0 [2]  
- [3] 
- [4] 
239-172-9 [5] 11138 -47-9 [1]  
12040 -72-1 [2]  
10332 -33-9 [3]  
- [4] 
15120 -21-5 [5] Ox. Sol. 3  
Repr. 1B  
Acute Tox. 3  
Acute Tox. 4  
STOT SE 3  
Eye Dam. 1  H272  
H360FD  
H331  
H302  
H335  
H318  GHS03  
GHS08  
GHS06  
GHS05  
Dgr H272  
H360FD  
H331  
H302  
H335 
H318   inhalation: 
ATE = 0,75 
mg/L (dusts or 
mists)  
oral: ATE = 
890 mg/kg bw  
Eye Dam. 1; 
H318:  
C ≥ 22 %  
Eye Irrit. 2; 
H319:  
14 % ≤ C < 22 
% 11’ 
‘005-023-00-X perboric acid (H 3BO 2(O2)), 
monosodium salt 
trihydrate [1]  
perboric acid, sodium salt, 
tetrahydrate [2]  
perboric acid (HBO(O 2)), 
sodium salt, tetrahydrate  
[3] sodium peroxoborate, 239-172-9 [1]  
234-390-0 [2]  
- [3] 
- [4] 13517 -20-9 [1]  
37244 -98-7 [2]  
10486 -00-7 [3]  
- [4] Repr. 1B  
Acute Tox. 4  
STOT SE 3  
Eye Dam. 1  H360FD  
H332  
H335  
H318  GHS08  
GHS05  
GHS07  
Dgr H360FD  
H332  
H335  
H318   inhalation: 
ATE = 1,2 
mg/L (dusts or 
mists)  
Eye Dam. 1; 
H318: C ≥ 36 
% 
Eye Irrit. 2; 11’  
EN 2  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
hexahydrate [ 4] H319: 22 % ≤ 
C < 36 %  
‘005-024-00-5 sodium peroxometaborate  231-556-4 7632 -04-4 Ox. Sol. 2  
Repr. 1B  
Acute Tox. 3 
Acute Tox. 4  
STOT SE 3  
Eye Dam. 1  H272  
H360FD  
H331  
H302  
H335  
H318  GHS03  
GHS08  
GHS06  
GHS05  
Dgr H272  
H360FD  
H330  
H302  
H335  
H318   inhalation: 
ATE = 0,62 
mg/L (dusts or 
mists)  
oral: ATE = 
730 mg/kg bw  
Eye Dam. 1; 
H318:  
C ≥ 22 %  
Eye Irrit. 2; 
H319: 14 % ≤ 
C < 22 %  11’ 
‘006-104-00-2 multi-walled carbon tubes 
(synthetic graphite in 
tubular shape) with a 
geometric tube diameter 
range ≥ 30 nm to < 3 µm 
and a length ≥ 5 µm and 
aspect ratio > 3:1, 
including multi-walled 
carbon nanotubes, 
MWC(N)T   -  - Carc. 1B  
STOT RE 1  H350i  
H372 
(lung)(inhal
ation)  GHS08  
Dgr H350i  
H372 
(lung)(inhalat
ion)  STOT RE 1; 
H372: C ≥ 1 
%; 
STOT RE 2; 
H373: 0,1 % ≤ 
C < 1 % ’  
‘029-026-00-0 copper; [specific surface 
area > 0.67 mm2/mg]  231-159-6 7440 -50-8 Aquatic Acute 1  
Aquatic Chronic 1  H400  
H410  GHS09  
Wng  H410   M = 10  
M = 1 ’   
EN 3  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
‘047-004-00-9 silver massive: [particle 
diameter ≥ 1 mm]  231-131-3 7440 -22-4 Repr. 2  
STOT RE 2  H361f  
H373 
(nervous 
system)  GHS08  
Wng  H361f  
H373 
(nervous 
system) ’    
‘047-005-00-4 silver powder: [particle 
diameter > 100 nm < 1 
mm]  231-131-3 7440 -22-4 Repr. 2  
STOT RE 2  
Aquatic Acute 1  
Aquatic Chronic 1  H361f  
H373 
(nervous 
system)  
H400  
H410  GHS08  
GHS09  
Wng  H361f  
H373 
(nervous 
system)  
H410    
 
M = 10  
M = 10 ’  
‘047-006-00-X silver nano: [particle 
diameter > 1 nm ≤ 100 
nm] 231-131-3 7440 -22-4 Repr. 2  
STOT RE 2  
Aquatic Acute 1  
Aquatic Chronic 1  H361f  
H373 
(nervous 
system)  
H400  
H410  GHS08  
GHS09  
Wng  H361f  
H373 
(nervous 
system)  
H410    
 
M = 1000  
M = 1000 ’  
‘603-247-00-8 reaction mass of 1,3 -
dioxan -5-ol and  1,3-
dioxolan -4-ylmethanol  - - Repr. 1B  H360Df  GHS08  
Dgr H360Df ’    
‘605-042-00-9 α-methyl -1,3-
benzodioxole -5-
propionaldehyde [1]  
(S)-α-methyl -1,3-
benzodioxole -5-
propionaldehyde;  
(2S)-3-(1,3-benzodioxol -5-214-881-6 [1]  
- [2] 
- [3] 1205 -17-0 [1]  
737776 -68-0 
[2] 
737776 -59-9 
[3] Skin Sens. 1B  H317  GHS07  
Wng  H317 ’     
EN 4  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
yl)-2-methylpropanal [2]  
(R)-α-methyl -1,3-
benzodioxole -5-
propionaldehyde;  
(2R)-3-(1,3-benzodioxol -
5-yl)-2-methylpropanal [3]  
‘605-043-00-4 2,4-dimethylcyclohex -3-
ene-1-carbaldehyde [1]   
(1α,2α,5α) -2,5-
dimethylcyclohex -3-ene-1-
carbaldehyde [2]  
2,6-dimethylcyclohex -3-
ene-1-carbaldehyde [3]  
3,5-dimethylcyclohex -3-
ene-1-carbaldehyde [4]  
3,6-dimethylcyclohex -3-
ene-1-carbaldehyde [5]  
4,6-dimet hylcyclohex -3-
ene-1-carbaldehyde [6]  
reaction mass of 3,5 -
dimethylcyclohex -3-ene-1-
carbaldehyde and 2,4 -
dimethylcyclohex -3-ene-1-
carbaldehyde [7]  
dimethylcyclohex -3-ene-1-
carbaldehyde [8]  
Dimethylcyclohex -3-ene-
1-carbaldehyde [9]  
1,2,4(or 1,3,5) -268-264-1 [1]  
252-395-6 [2]  
 - [3]  
268-263-6 [4]  
267-186-5 [5]  
253-139-6 [6]  
- [7]  
248-742-6 [8]  
272-113-5 [9]  
276-055-1 [10]  
- [11]  
- [12] 
215-833-7 [13]  
215-638-7 [14]  
266-810-3 [15]  
- [16] 68039 -49-6 [1]  
35145 -02-9 [2]  
6975 -94-6 [3]  
68039 -48-5 [4]  
67801 -65-4 [5]  
36635 -35-5 [6]  
- [7]  
27939 -60-2 [8]  
68737 -61-1 [9]  
71832 -78-5 
[10]  
40702 -26-9 
[11]  
1726 -47-2 [12]  
1423 -46-7 [13]  
1335 -66-6 [14]  
67634 -07-5 
[15]  
6754 -27-4 [16]  Skin Sens. 1  H317  GHS07  
Wng  H317 ’      
EN 5  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
trimet hylcyclohex -3-ene-
1-carbaldehyde [10]  
1,3,4 -trimethylcyclohex -3-
ene-1-carbaldehyde [11]  
2,2,4 -trimethylcyclohex -3-
ene-1-carbaldehyde [12]  
2,4,6 -trimethylcyclohex -3-
enecarbaldehyde [13]  
isocyclocitral [14]  
3,5,6 -trimethylcyclohex -3-
ene-1-carbaldehyde [ 15]  
4,6,6 -trimethylcyclohex -3-
ene-1-carbaldehyde [16]  
‘606-156-00-1 acetone oxime  204-820-1 127-06-0 Carc. 1B  
Acute Tox. 4  
STOT SE 3  
STOT RE 2  
Eye Dam. 1  
Skin Sens. 1  H350  
H312  
H336  
H373 
(blood 
system)  
H318  
H317  GHS08  
GHS07  
GHS05  
Dgr H350  
H312  
H336  
H373 (blood 
system)  
H318  
H317   dermal: ATE = 
1100 mg/kg 
bw’  
‘606-157-00-7 (3E)-dec-3-en-2-one  - 18402 -84-1 Acute Tox. 4  
Asp. Tox. 1  
Skin Irrit. 2 
Aquatic Chronic 2  H332  
H304  
H315  
H411  GHS07  
GHS08  
GHS09  
Dgr H332  
H304  
H315  
H411  EUH071  inhalation: 
ATE = 1,5 
mg/L (dusts or 
mists) ’  
‘606-158-00-2 2-(dimethylamino) -2-[(4-
methylphenyl)methyl] -1-438-340-0 119344 -86-4 Repr. 1B  
Aquatic Acute 1  H360Df  
H400  GHS08  
GHS09  H360Df  
H410    
M = 1    
EN 6  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
[4-(morpholin -4-
yl)phenyl]butan -1-one Aquatic Chronic 1  H410  Dgr M = 1 ’ 
‘607-770-00-2 2,3-epoxypropyl 
neodecanoate  247-979-2 26761 -45-5 Muta. 2  
Skin Sens. 1A  H341  
H317  GHS08  
GHS07  
Wng  H341  
H317   Skin Sens. 1A; 
H317: C ≥ 
0,001% ’  
‘607-771-00-8 benthiavalicarb -isopropyl 
(ISO); isopropyl [( S)-1-
{[(R)-1-(6-fluoro -1,3-
benzothiazol -2-
yl)ethyl]carbamoyl} -2-
methylpropyl]carbamate   - 177406 -68-7 Carc. 1B  
Repr. 2  
Skin Sens. 1  
Aquatic Chronic 2  H350  
H361fd  
H317  
H411  GHS08  
GHS07  
GHS09  
Dgr H350  
H361fd  
H317  
H411 ’    
‘607-772-00-3 hexyl salicylate  228-408-6 6259 -76-3 Repr. 2  
Skin Sens. 1  H361d  
H317  GHS08  
GHS07  
Wng  H361d  
H317 ’    
‘607-773-00-9 7-oxabicyclo[4.1.0]hept -3-
ylmethyl 7 -
oxabicyclo[4.1.0]heptane -
3-carboxylate  219-207-4 2386 -87-0 Muta. 2  
STOT RE 2  
Skin Sens. 1  H341  
H373 (nasal 
cavity)  
H317  GHS08  
GHS07  
Wng  H341  
H373 (nasal 
cavity)  
H317 ’    
‘607-774-00-4 tetrasodium 4 -amino -5-
hydroxy -3,6-bis[[4 -[[2-
(sulphonatooxy)  
ethyl]sulphonyl]phenyl]az
o]naphthalene -2,7-
disulphonate [1]  
Reaction products of 4 -241-164-5 [1]  
- [2] 
- [3] 17095 -24-8 [1]  
- [2] 
100556 -82-9 
[3] Resp. Sens. 1A  
Skin Sens. 1  H334  
H317  GHS08  
Dgr H334  
H317 ’     
EN 7  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
amino -5-
hydroxynaphthalene -2,7-
disulfonic acid, coupled 
twice with diazotized 2 -
[(4-
aminophenyl)sulfonyl]ethy
l hydrogen sulfate, sodium 
salts [2]  
disodium 4 -amino -5-
hydroxy -3,6-bis{[4 -
(vinylsulfonyl) 
phenyl]diazenyl}naphthale
ne-2,7-disulfonate [3]  
‘607-775-00-X Sodium 3 -(allyloxy) -2-
hydroxypropanesulphonate  258-004-5 52556 -42-0 Repr. 1B  
Eye Dam. 1  H360F  
H318  GHS08  
GHS05  
Dgr H360F  
H318 ’    
‘609-074-00-4 1,4-dichloro -2-
nitrobenzene  201-923-3 89-61-2 Carc. 1B  H350  GHS08  
Dgr H350 ’    
‘611-182-00-1 2-[ethyl[3 -methyl -4-[(5-
nitrothiazol -2-
yl)azo]phenyl]amino]ethan
ol 271-183-4 68516 -81-4 Skin Sens. 1A  H317  GHS07  
Wng  H317   Skin Sens. 1A; 
H317: C ≥ 
0,001% ’  
‘612-299-00-0 fenpropidin (ISO);  (R,S)-
1-[3-(4-tert-butylphenyl) -
2-methylpropyl]piperidine  - 67306 -00-7 Repr. 2  
Acute Tox. 4  
Acute Tox. 4  
STOT SE 3  H361d  
H332  
H302  
H335  GHS08  
GHS07  
GHS05  
GHS09  H361d  
H332  
H302  
H335   Inhalation: 
ATE = 1.2 
mg/L (dusts or 
mists)    
EN 8  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M - 
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
STOT SE 3  
STOT RE 2  
Skin Irrit. 2 
Eye Dam. 1  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H336  
H373 
(nervous 
system, 
eyes, lungs)  
H315  
H318  
H317  
H400  
H410  Dgr H336  
H373 
(nervous 
system, eyes, 
lungs)  
H315  
H318  
H317  
H410  oral: ATE = 
1330 mg/kg 
bw 
 
 
 
 
 
 
M = 1000  
M = 10000 ’ 
‘613-350-00-X 1H-benzotriazole  202-394-1 95-14-7 Aquatic Chronic 2  H411  GHS09  
Wng  H411 ’    
‘613-351-00-5 methyl -1H-benzotriazole  249-596-6 29385 -43-1 Aquatic Chronic 2  H411  GHS09  
Wng  H411 ’    
‘616-243-00-6 N,N'-
methylenediacrylamide  203-750-9 110-26-9 Muta. 1B  H340  GHS08  
Dgr H340 ’    
‘617-024-00-8 tert-butyl 2 -
ethylperoxyhexanoate  221-110-7 3006 -82-4 Repr. 1B  
Skin Sens. 1  H360FD  
H317  GHS08  
GHS07  
Dgr H360FD  
H317 ’    
 
(2) the entries corresponding to index numbers  005-005-00-1, 016-022-00-9, 016-094-00-1, 029-019-01-X, 601-037-00-0, 604 -020-00-6, 
605-001-00-5, 607 -001-00-0, 607 -043-00-X, 607 -094-00-8, 607 -198-00-3, 607 -315-00-8, 607 -432-00-4, 613 -272-00-6, 616 -127-00-5 
and 617 -008-00-0 are replaced by the following entries respectively:    
EN 9  EN  
Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M-
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
‘005-005-00-1 trimethyl borate  204-468-9 121-43-7 Flam. Liq. 3  
Repr. 1B  
Acute Tox. 4*  
 H226  
H360FD  
H312  
 GHS02  
GHS08  
GHS07  
Dgr H226  
H360FD  
H312  
   11’ 
‘016-022-00-9 ethanethiol;  
ethyl mercaptan  200-837-3 75-08-1 Flam. Liq. 1  
Acute Tox. 3  
Acute Tox. 4  
Aquatic Acute 1  
Aquatic Chronic 1  H224  
H331  
H302  
H400  
H410  GHS02  
GHS06  
GHS09  
Dgr H224  
H331  
H302  
H410   inhalation: 
ATE = 7,1 
mg/L 
(vapours)  
oral: ATE = 
680 mg/kg 
bw’  
‘016-094-00-1 sulfur  231-722-6 7704 -34-9 Skin Irrit. 2  H315  GHS07  
Wng  H315     
‘029-019-01-X copper  flakes (coated 
with  
aliphatic acid)    Acute Tox. 3 
Acute Tox. 4  
Eye Irrit. 2 
Aquatic Acute 1 
Aquatic Chronic 1  H331  
H302  
H319 
H400 
H410  GHS06  
GHS09  
Dgr H331  
H302  
H319  
H410   inhalation: 
ATE =  
0,733 mg/l 
(dusts  
or mists)  
oral: ATE =  
500 mg/kg bw  
M = 10  
M = 1   
‘601-037-00-0 n-hexane  203-777-6 110-54-3 Flam. Liq. 2  
Repr. 2  H225  
H361f***  GHS02  
GHS08  H225  
H361f***      
EN 10  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M-
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
Asp. Tox. 1  
STOT SE 3  
STOT RE 1  
Skin Irrit. 2 
Aquatic Chronic 2  H304  
H336  
H372 (nervous 
system)  
H315  
H411  GHS07  
GHS09  
Dgr H304  
H336  
H372 (nervous 
system)  
H315  
H411  
‘604-020-00-6 biphenyl -2-ol; 2-
phenylphenol; 2 -
hydroxybiphenyl  201-993-5 90-43-7 Carc. 2  
Skin Corr. 1  
Eye Dam. 1  
Skin Sens. 1B  
Aquatic Acute 1  
Aquatic Chronic 1  H351  
H314  
H318  
H317  
H400  
H410  GHS08  
GHS05  
GHS07  
GHS09  
Dgr H351  
H314  
H317  
H410    
 
M = 1  
M = 1 ’ 
 
‘605-001-00-5 formaldehyde … %  200-001-8 50-00-0 Carc. 1B  
Muta. 2  
Acute Tox. 2  
Acute Tox. 4  
Skin Corr. 1B  
Skin Sens. 1A  H350  
H341  
H330  
H302  
H314  
H317  GHS08  
GHS06  
GHS05  
Dgr H350  
H341  
H330  
H302  
H314  
H317  EUH071  inhalation: 
ATE = 100 
ppmV (gases)  
oral: ATE = 
500 mg/kg bw  
STOT SE 3; 
H335: C ≥ 5 
% 
Skin Corr. 1B; 
H314: C ≥ 25 
% 
Skin Irrit. 2; 
H315: 5 % ≤ 
C < 25 %  
Eye Irrit. 2; 
H319: 5 % ≤ B, D, F ’  
EN 11  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M-
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
C < 25 %  
‘607-001-00-0 formic acid ... %  200-579-1 64-18-6 Flam. Liq. 3  
Met. Corr. 1  
Acute Tox. 3  
Acute Tox. 4  
Skin Corr. 1A  
Eye Dam. 1  H226  
H290  
H331  
H302  
H314  
H318  GHS02  
GHS05  
GHS06  
Dgr H226  
H290  
H331  
H302  
H314  EUH071  inhalation: 
ATE = 7,4 
mg/L 
(vapours)  
oral: ATE = 
500 mg/kg bw  
Flam. Liq. 3; 
H226: C > 
85% 
Skin Corr. 
1A; H314: C 
≥ 90%  
Skin Corr. 1B; 
314: 10% ≤ C 
< 90%  
Skin Irrit. 2; 
H315: 2% ≤ C 
< 10%  
Eye Dam. 1; 
H318: C ≥ 
10% 
Eye Irrit. 2; 
H319: 2% ≤ C 
< 10% ’  
‘607-043-00-X dicamba (ISO); 2,5 -
dichloro -6-
methoxybenzoic 
acid; 3,6 -dichloro -2-217-635-6 1918 -00-9 Acute Tox. 4  
Acute Tox. 4  
STOT SE 3  
STOT SE 3  H332  
H302  
H335  
H336  GHS07  
GHS05  
GHS09  H332  
H302  
H335  
H336   inhalation: 
ATE = 4,0 
mg/L (dusts or 
mists)    
EN 12  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M-
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
methoxybenzoic acid  Eye Dam. 1  
Aquatic Acute 1  
Aquatic Chronic 2  H318  
H400  
H411  Dgr H318  
H410  oral: ATE = 
1500 mg/kg 
bw  
M = 1 ’ 
‘607-094-00-8 peracetic acid … %  201-186-8 79-21-0 Org. Perox. D  
Acute Tox. 2  
Acute Tox. 2  
Acute Tox. 3  
Skin Corr. 1A  
Aquatic Acute 1  
Aquatic Chronic 1  H242  
H330  
H310  
H301  
H314  
H400  
H410  GHS02  
GHS06  
GHS05  
GHS09  
Dgr H242  
H330  
H310  
H301  
H314  
H410  EUH071  inhalation: 
ATE = 0,2 
mg/L (dusts or 
mists)  
dermal: ATE 
= 60 mg/kg 
bw  
oral: ATE = 
80 mg/kg bw  
STOT SE 3; 
H335: C ≥ 1 
% 
M = 10  
M = 100  B, D, T ’ 
‘607-198-00-3 propyl 3,4,5 -
trihydroxybenzoate  204-498-2 121-79-9 Acute Tox. 4  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H302  
H317  
H400  
H410  GHS07  
GHS09  
Wng  H302  
H317  
H410   oral: ATE = 
1700 mg/kg 
bw 
M = 1  
M = 1 ’  
‘607-315-00-8 glyphosate (ISO); N- 
(phosphonomethyl)gl
ycine  213-997-4 1071 -83-6 Eye Dam. 1  
Aquatic Chronic 2  H318  
H411  GHS05  
GHS09  
Dgr H318  
H411 ’     
EN 13  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M-
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
‘607-432-00-4 S-metolachlor (ISO); 
2-chloro -N-(2-ethyl -
6-methylphenyl) -N-
[(2S)-1-
methoxypropan -2-
yl]acetamide ; (RaSa)-
2-chloro -N-(6-ethyl -
o-tolyl) -N-[(1S)-2-
methoxy -1-
methylethyl]acetami
de 
 
[contains 80 -100% 
2-chloro -N-(2-ethyl -
6-methylphenyl) -N-
[(2S)-1-
methoxypropan -2-
yl]acetamide and 0 -
20% 2 -chloro -N-(2-
ethyl -6-
methylphenyl) -N-
[(2R)-1-
methoxypropan -2-
yl]acetamide]   - 87392 -12-9 Carc. 2  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H351  
H317  
H400  
H410  GHS08  
GHS07  
GHS 09 
Wng  H351  
H317  
H410  EUH066   
 
M = 10  
M = 10 ’  
‘613-272-00-6 pyraclostrobin (ISO); 
methyl N-(2-{[1-(4-
chlorophenyl) -1H-
pyrazol -3-- 175013 -18-0 Repr. 2  
Acute Tox. 3  
Acute Tox. 4  
STOT SE 3  H361d  
H331  
H302  
H335  GHS08  
GHS06  
GHS09  H361d  
H331  
H302  
H335   inhalation: 
ATE = 0,58  
mg/L ( dusts or  
mists)    
EN 14  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M-
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
yl]oxymethyl}phenyl
) N-methoxy 
carbamate  STOT RE 2  
Skin Irrit. 2 
Aquatic Acute 1  
Aquatic Chronic 1  H373 (liver, 
gastrointestina
l tract, nasal 
cavity)  
H315  
H400  
H410  Dgr  H373 (liver, 
gastrointestinal 
tract, nasal 
cavity)  
H315  
H410  oral: ATE = 
450 
mg/kg bw  
M = 100  
M = 100 ’ 
‘616-127-00-5 reaction mass of 
N,N'-ethane -1,2-
diylbis(decanamide) 
and 12 -hydroxy -N-
[2-[(1-
oxodecyl)amino]ethy
l]octadecanamide 
and N,N'-ethane -1,2-
diylbis(12 -
hydroxyoctadecanam
ide) [1]  
reaction mass of 
N,N'-ethane -1,2-
diylbis(decanamide) 
and 12 -hydroxy -N-
[2-[(1-
oxodecyl)amino]ethy
l]octadecanamide [2]  430-050-2 [1]  
- [2]  - [1] 
 - [2] Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H317  
H400  
H410  GHS07  
GHS09  
Wng  H317  
H410   M = 100  
M = 10 ’  
‘617-008-00-0 dibenzoyl peroxide; 
benzoyl peroxide  202-327-6 94-36-0 Org. Perox. B  
Eye Irrit. 2  
Skin Sens. 1  H241  
H319  
H317  GHS01  
GHS02  
GHS07  H241  
H319  
H317    
 
M = 10    
EN 15  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. 
Limits, M-
factors and 
ATE  Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
Aquatic Acute 1  
Aquatic Chronic 1  H400  
H410  GHS09  
Dgr H410  M = 10 ’ 
(3) the entr y corresponding to index number  029-024-00-X is deleted.